Abstract:The histamine H4 receptor (H4R) was first noted as a sequence in genomic databases that had features of a class A G-protein coupled receptor. This putative receptor was found to bind histamine consistent with its homology to other histamine receptors and thus became the fourth member of the histamine receptor family. Due to the previous success of drugs that target the H1 and H2 receptors, an effort was made to understand the function of this new receptor and determine if it represented a viable drug target. Taking advantage of the vast literature on the function of histamine, a search for histamine activity that did not appear to be mediated by the other three histamine receptors was undertaken. From this asthma and pruritus emerged as areas of particular interest. Histamine has long been suspected to play a role in the pathogenesis of asthma, but antihistamines that target the H1 and H2 receptors have not been shown to be effective for this condition. The use of selective ligands in animal models of asthma has now potentially filled this gap by showing a role for the H4R in mediating lung function and inflammation. A similar story exists for chronic pruritus associated with conditions such as atopic dermatitis. Antihistamines that target the H1 receptor are effective in reducing acute pruritus, but are ineffective in pruritus experienced by patients with atopic dermatitis. As for asthma, animal models have now suggested a role for the H4R in mediating pruritic responses, with antagonists of the H4R reducing pruritus in a number of different conditions. The anti-pruritic effect of H4R antagonists has recently been shown in human clinical studies, validating the preclinical findings in the animal models. A selective H4R antagonist inhibited histamine-induced pruritus in health volunteers and reduced pruritus in patients with atopic dermatitis. The history to date of the H4R provides an excellent example of the deorphanization of a novel receptor and the translation of this into clinical efficacy in humans.

Histamine receptors, agonists, and antagonists in health and disease

Histamine: neural circuits and new medications

Update on Histamine and Antihistamines

Histamine pharmacology: from Sir Henry Dale to the 21st century

The Role of Histamine and Histamine Receptors in Mast Cell-Mediated Allergy and Inflammation: The Hunt for New Therapeutic Targets

Histamine in the Crosstalk Between Innate Immune Cells and Neurons: Relevance for Brain Homeostasis and Disease

The Function of the Histamine H4 Receptor in Inflammatory and Inflammation-Associated Diseases of the Gut

Progress of Histamine H3 Receptor Antagonist

Opportunities and challenges in the therapeutic exploitation of histamine and histamine receptor pharmacology in inflammation-driven disorders

Advances on Research of Function and Regulatory Mechanism of Histamine H1 Receptor

Classification and biological distribution of histamine receptor sub-types

The Role in Neurodevelopmental and Neurodegenerative Disorders

The Histaminergic System in Neuropsychiatric Disorders

Application of Histamine Receptors H2R, H3R and H4R, but Not H1R, in Dermatology

The histamine H4 receptor: from orphan to the clinic

Role of histamine and its receptors in cerebral ischemia.

Histamine, histamine receptors, and neuropathic pain relief

Revisiting Preclinical Observations of Several Histamine H3 Receptor Antagonists/Inverse Agonists in Cognitive Impairment, Anxiety, Depression, and Sleep–Wake Cycle Disorder

Histamine H1 receptor on astrocytes and neurons controls distinct aspects of mouse behaviour

Histamine and receptors in neuroinflammation: Their roles on neurodegenerative diseases

[Physiological function mediated by histamine synthesis]